BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3487144)

  • 1. Immunologic effects of cyclosporine.
    Wish JB
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):15-8. PubMed ID: 3487144
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine A inhibits accessory cell and antigen-presenting cell functions of epidermal Langerhans cells.
    Furue M; Katz SI
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):87-91. PubMed ID: 3259044
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine A: a tool for analyzing the function of class I MHC antigen-reactive T cells in vivo.
    Hodgkin PD; Dixon JE; Andrus L; Lafferty KJ
    Transplant Proc; 1984 Aug; 16(4):968-9. PubMed ID: 6611620
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine A inhibition of alloantigen presentation.
    Little RG; Ebertowski LA; David CS
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):6-9. PubMed ID: 1829555
    [No Abstract]   [Full Text] [Related]  

  • 5. Important role of cyclosporine for the induction of immunologic tolerance in adult hosts.
    Kahan BD; Didlake R; Kim EE; Yoshimura N; Kondo E; Stepkowski S
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):438-50. PubMed ID: 2966480
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class-II restriction of antigen-specific T-cell activation. With special reference to the fine specificity and immunoregulation of HLA class-II restriction elements.
    Qvigstad E; Scott H; Thorsby E
    Prog Allergy; 1985; 36():73-94. PubMed ID: 3881783
    [No Abstract]   [Full Text] [Related]  

  • 8. Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation.
    Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    Hum Immunol; 2004 Apr; 65(4):328-39. PubMed ID: 15120187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of receptors for interleukin 2 requires T cell Ag:Ia receptor crosslinking and interleukin 1.
    Kaye J; Janeway CA
    Lymphokine Res; 1984; 3(4):175-82. PubMed ID: 6436584
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of immunological parameters in kidney transplantation.
    Kreisler JM
    Proc Eur Dial Transplant Assoc; 1983; 19():407-23. PubMed ID: 6348742
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of cyclosporin A on the immune system.
    Shevach EM
    Annu Rev Immunol; 1985; 3():397-423. PubMed ID: 3933532
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of action of cyclosporine: effect on cells of the immune system and on subcellular events in T cell activation.
    Hess AD; Esa AH; Colombani PM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):29-40. PubMed ID: 2834840
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of MHC product induction may contribute to the immunosuppressive action of ciclosporin.
    Halloran PF; Wadgymar A; Autenried P
    Prog Allergy; 1986; 38():258-68. PubMed ID: 2425369
    [No Abstract]   [Full Text] [Related]  

  • 14. Preclinical evaluation of immunosuppression selective for T cells recognizing class I histocompatibility antigens.
    Wright JK; Barrett LV; Delmonico FL; Fuller TC; Cosimi AB
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1106-9. PubMed ID: 3547852
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.
    Berzofsky JA
    J Clin Invest; 1988 Dec; 82(6):1811-7. PubMed ID: 2974044
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
    Tite JP; Sloan A; Janeway CA
    J Mol Cell Immunol; 1986; 2(4):179-90. PubMed ID: 3509916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presenting cells and mechanisms of antigen presentation.
    Chesnut RW; Grey HM
    Crit Rev Immunol; 1985; 5(3):263-316. PubMed ID: 3884274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal effect of cyclosporine immunosuppression on T lymphocyte subsets, Ia-reactive cells, and donor-specific immunity in cardiac allograft recipients.
    Mazaheri R; Stiller CR; Keown P; McKenzie N; Howson W; Farrow K; McFarlane D; Sinclair NR
    Transplant Proc; 1984 Dec; 16(6):1537-9. PubMed ID: 6390861
    [No Abstract]   [Full Text] [Related]  

  • 20. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
    Palacios R
    J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.